Aimee Wilkin to Reverse Transcriptase Inhibitors
This is a "connection" page, showing publications Aimee Wilkin has written about Reverse Transcriptase Inhibitors.
Connection Strength
0.130
-
Floris-Moore MA, Mollan K, Wilkin AM, Johnson MA, Kashuba AD, Wohl DA, Patterson KB, Francis O, Kronk C, Eron JJ. Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results. Antivir Ther. 2016; 21(1):55-64.
Score: 0.130